The drugs singled out for discounts include the flagging hepatitis C treatment Zepatier and six drugs that have lost their patent protection.
KATIE THOMAS, NY Times: Science
Thu, 07/19/2018 - 3:19pm
The drugs singled out for discounts include the flagging hepatitis C treatment Zepatier and six drugs that have lost their patent protection.